"The first vaccine trial has begun, just 60 days after the genetic sequence of the coronavirus was shared. This is an incredible achievement. We commend the researchers around the world who have come together to systemically evaluate experimental therapeutics," WHO Director-General Tedros Adhanom Ghebreyesus said.
He also called on all countries to take an integrated approach in order to slow COVID-2019 transmission.
As we reported earlier, the National Medical Products Administration of China approved the first-ever antiviral medicine called Favilavir.
This medicine is said to possibly treat the now-declared pandemic illness.
According to the Science Times, Favilavir functions as an effective antiviral drug to fight RNA infections by inhibiting the RNA-dependent RNA polymerase or the RdRp. Besides, this drug is mainly taken as an effective treatment for influenza in Japan and China.